ENT features archive for 2026
A shifting landscape of otitis media
In light of pneumococcal vaccination programmes, is otitis media evolving to have a different natural history? Acute otitis media (AOM) is a major public health problem in children worldwide, as it is the leading bacterial infection and first cause of...
Young CEORL-HNS: growing a pan-European ENT network
We are seeing a growth in the number of organisations supporting young ENT surgeons. Young CEORL-HNS is a thriving and expanding group. The Young Confederation of European ORL-HNS (Y-CEORL) was created with a simple idea in mind: to give young...
ENTelligence: driving safe and transparent AI innovation in ENT
AI is seemingly going to be ubiquitous. How do we as ENT clinicians help to shape its direction? Artificial Intelligence (AI) is reshaping modern medicine. Algorithmic analysis is now influencing decisions once made solely by clinicians. Yet, in surgical specialties...
The MACRO Trial: defining best management of chronic rhinosinusitis
A major UK trial in The Lancet finds ESS provides greater symptom relief than long-term macrolides for adults with CRS, supporting earlier surgery and fewer antibiotics. The MACRO Programme was established in 2016 when the UK National Institute of Health...
